These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 535177)

  • 21. Weight changes with depot neuroleptic maintenance therapy.
    Johnson DA; Breen M
    Acta Psychiatr Scand; 1979 May; 59(5):525-8. PubMed ID: 463589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
    Coufal J; Novotný M
    Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
    [No Abstract]   [Full Text] [Related]  

  • 24. Flupenthixol versus combined fluphenazine-nortriptyline in depressive illness.
    Conway JF
    Practitioner; 1981 Mar; 225(1353):400-4. PubMed ID: 7022433
    [No Abstract]   [Full Text] [Related]  

  • 25. Lowest effective dose of depot neuroleptics.
    Hoencamp E; Haffmans PJ; Jansen GS
    Br J Psychiatry; 1992 Mar; 160():422-3. PubMed ID: 1348655
    [No Abstract]   [Full Text] [Related]  

  • 26. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS; Yeo SH
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
    Wistedt B; Ranta J
    Acta Psychiatr Scand; 1983 Jun; 67(6):378-88. PubMed ID: 6349256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J; Villiger J; Hunter L
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term treatment of periodical and cyclic depressions with flupenthixol decanoate.
    Kielholz P; Terzani S; Pöldinger W
    Int Pharmacopsychiatry; 1979; 14(6):305-9. PubMed ID: 548504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative trial of the decanoates of flupenthixol and fluphenazine.
    Hamilton M; Card IR; Wallis GG; Mahmoud MR
    Psychopharmacology (Berl); 1979 Aug; 64(2):225-9. PubMed ID: 115046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Depot neuroleptics.
    Bennie EH
    Br Med J; 1976 Jun; 1(6022):1404. PubMed ID: 1276715
    [No Abstract]   [Full Text] [Related]  

  • 33. Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics.
    Wistedt B; Wiles D; Kolakowska T
    Lancet; 1981 May; 1(8230):1163. PubMed ID: 6112518
    [No Abstract]   [Full Text] [Related]  

  • 34. Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.
    Gerlach J; Kramp P; Kristjansen P; Lauritsen B; Lühdorf K; Munkvad I
    Acta Psychiatr Scand; 1975 Aug; 52(2):132-44. PubMed ID: 1096541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotropic drugs in depot form.
    Cook AR
    Br Med J; 1976 Sep; 2(6037):700. PubMed ID: 974557
    [No Abstract]   [Full Text] [Related]  

  • 36. Flupenthixol decanoate - controlled investigation concerning dosage -.
    Agrup-Andersson L; Bengtsson A; Erlandsson K; Gottfries CG; Witzell-Ostlund G
    Acta Psychiatr Scand Suppl; 1974; 255():7-14. PubMed ID: 4618720
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
    Johnson DA; Malik NA
    Acta Psychiatr Scand; 1975 May; 51(4):257-67. PubMed ID: 1096536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
    Dencker SJ; Malm U; Jørgensen A; Overø KF
    Acta Psychiatr Scand Suppl; 1980; 279():55-63. PubMed ID: 6931473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady-state serum concentrations after cis (Z)-flupentixol decanoate in viscoleo.
    Saikia JK; Jørgensen A
    Psychopharmacology (Berl); 1983; 80(4):371-3. PubMed ID: 6414008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prolonged action neuroleptics (review of the foreign literature)].
    Obukhov GA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(2):285-95. PubMed ID: 235182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.